Terrestrial Bio, Inc.
Biotechnology · WOBURN, MA
BiotechnologySEC Form D
Terrestrial Bio, Inc. filed a Form D with the U.S. Securities and Exchange Commission on March 19, 2026, reporting $57,301,758 raised toward a $83,538,199 offering.
Incorporated in Delaware and based in WOBURN, MA, it operates in the Biotechnology sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Terrestrial Bio, Inc. has raised capital from private investors.
Browse more recently funded companies in Biotechnology.
Executives & Directors
- Rachel ShaExecutive Officer · Director
- Kathryn KousdaExecutive Officer · Director
- Ann DeWittDirector
- Livio ValentiExecutive Officer
- Peter KolchinskyDirector
- Fenel EloiDirector
- Linda TusseyExecutive Officer
Recently funded in Biotechnology
Other companies that recently filed a Form D
$3.2MRaised
Goldenrod Therapeutics, Inc.
$10.0MRaised
Human Biotech, Inc.
$1.0MRaised
Optimeos Life Sciences, Inc.
$2.5MRaised
BioStem Technologies, Inc.
$1.6MRaised